Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: VLAD who wrote (18760)	2/14/1999 11:18:00 AM
From: Greg22	Respond to of 23519

VLAD, I agree with your valuations of Vivus that you described earlier. In fact, I believe that the work of Crist and Gusendheit alone is worth $75 million. If Vivus is able to sign a partner, more power to 'em. If Viagra is black boxed that is great as well. This will ramp the earnings to over $1 or maybe to $2 in the years to come. This would put the buyout price at $35-70 a share. I like to assume the worst case scenario. This would be a buyout at $10-$11 a share. Leland will (should) do whatever is best for the shareholder value. If it is best to wait a year or two, so be it. However, there is a cost and a risk to waiting. On another point, the hedged (shorts) have to become impatient, since it is very costly to hold a short position that is going nowhere. I think this is what we are starting to see...did you notice the 50,000 shares bought in the last 5 minutes of trading Friday?